Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.

ABSTRACT:

Background

Stereotactic body radiotherapy (SBRT) for localized prostate cancer has potential advantages over traditional radiotherapies. Herein, the authors compared national trends in use, complications, and costs of SBRT with those of traditional radiotherapies.

Methods

The authors identified men who underwent SBRT, intensity-modulated radiotherapy (IMRT), brachytherapy, and proton beam therapy as primary treatment of prostate cancer between 2004 and 2011 from Surveillance, Epidemiology, and End Results Program (SEER)-Medicare linked data. Temporal trend of therapy use was assessed using the Cochran-Armitage test. Two-year outcomes were compared using the chi-square test. Median treatment costs were compared using the Kruskal-Wallis test.

Results

A total of 542 men

SUBMITTER: Halpern JA 

PROVIDER: S-EPMC4974119 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature